Tranexamic Acid Injection, Solution
Product Images NDC 51662-1532

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 51662-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Case Labeling (51662 1532 3 Case Labeling)

Label for TRANEXAMIC ACID injection, USP, 100 mg/mL strength. The product is supplied as a 10 mL vial, with a box containing 10 vials. The label includes the NDC 51662-1532-3, lot number 12345, and an expiration date of 2025-01-01. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Description (Description)

Chemical structure diagram of tranexamic acid showing its molecular arrangement with an amino group and carboxylic acid group attached to a cyclohexane ring.*

FDA Label Image

Dosage (Dosage)

A data table titled "Table 1. Recommended Dosage in Patients With Varying Degrees of Renal Impairment" showing serum creatinine ranges in mg/dL with corresponding intravenous dosages of Tranexamic Acid Injection. The table includes dosage recommendations based on creatinine levels from 1.36 to greater than 5.66 mg/dL.*

FDA Label Image

Pouch Labeling (Pouch)

Label for TRANEXAMIC ACID Injection USP showing 1,000 mg per 10 mL (100 mg/mL) in a 10 mL vial. The label includes NDC 51662-1532-2, lot number 12345, expiration date 2025-01-01, and manufacturer HF Acquisition Co., LLC, Mukilteo, WA. Text indicates intravenous use only and storage instructions.*

FDA Label Image

Seerialized Labeling (Serialized Labeling)

A small white adhesive label on packaging showing a GS1 barcode with product and lot identification numbers. The label includes the text: 'See manufacturer's package insert. Distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275' and 'RX ONLY' on the right side.*

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

Tranexamic Acid Injection USP 100 mg/mL solution in a 10 mL sterile single-dose vial with a yellow cap. The label indicates it is for intravenous use only and is distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial includes a barcode and NDC numbers visible on the label.*

FDA Label Image

Vial Labeling (Vial Label)

The label displays Tranexamic Acid Injection, USP at 100 mg/mL strength, with a total of 1,000 mg per 10 mL vial for intravenous use only. It is a sterile, single-dose solution vial. The product is distributed by AuroMedics Pharma LLC, made in India, and includes storage instructions and a barcode.*

FDA Label Image

Vial (Vial Label Update)

Label for Tranexamic Acid Injection, USP 100 mg/mL in a 10 mL sterile single-dose vial, intended for intravenous use only. Distributed by AuroMedics Pharma LLC, the label includes storage instructions (20° to 25°C), dosage instructions to see prescribing information, barcode, and QR code. The product is Rx only and made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.